APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cyanocobalamin API

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Cyanocobalamin API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173981810331 December 2025199 pages

Choose your research edition.

Industry ResearchCyanocobalamin API Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Cyanocobalamin API Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Cyanocobalamin API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cyanocobalamin API Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Cyanocobalamin API Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Cyanocobalamin API market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Cyanocobalamin API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cyanocobalamin API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cyanocobalamin API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Cyanocobalamin API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cyanocobalamin API include Sanofi, Kingvit, North China Pharmaceutical Group, Hebei Yuxing Bio-Engineering, Hebei Huarong Pharmaceutical, GlaxoSmithKline, Wockhardt, Rochem International and EuroAPI, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Cyanocobalamin API market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cyanocobalamin API and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cyanocobalamin API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cyanocobalamin API market size, projected growth trends, production technologies, key applications, and end-use industries.

Cyanocobalamin API Segment by Company

Sanofi

Kingvit

North China Pharmaceutical Group

Hebei Yuxing Bio-Engineering

Hebei Huarong Pharmaceutical

GlaxoSmithKline

Wockhardt

Rochem International

EuroAPI

Bristol Myers Squibb

Basic Nutrition

Antibiotice

Cyanocobalamin API Segment by Type

Crystal

Powder

Cyanocobalamin API Segment by Application

Contract Manufacturing Organizations

Pharmaceutical Companies

Others

Cyanocobalamin API Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cyanocobalamin API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cyanocobalamin API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cyanocobalamin API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cyanocobalamin API market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cyanocobalamin API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Cyanocobalamin API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Cyanocobalamin API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Cyanocobalamin API Industry Trends Table 2. Cyanocobalamin API Industry Drivers Table 3. Cyanocobalamin API Industry Opportunities and Challenges Table 4. Cyanocobalamin API Industry Restraints Table 5. Global Cyanocobalamin API Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Cyanocobalamin API Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Cyanocobalamin API Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Cyanocobalamin API Sales Market Share by Manufacturers Table 9. Global Cyanocobalamin API Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Cyanocobalamin API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Cyanocobalamin API Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Cyanocobalamin API Manufacturers, Product Type & Application Table 13. Global Cyanocobalamin API Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Cyanocobalamin API by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Crystal Table 17. Major Manufacturers of Powder Table 18. Global Cyanocobalamin API Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Cyanocobalamin API Sales by Type (2021-2026) & (K Units) Table 20. Global Cyanocobalamin API Sales by Type (2027-2032) & (K Units) Table 21. Global Cyanocobalamin API Sales Market Share by Type (2021-2026) Table 22. Global Cyanocobalamin API Sales Market Share by Type (2027-2032) Table 23. Global Cyanocobalamin API Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Cyanocobalamin API Revenue by Type (2021-2026) & (K Units) Table 25. Global Cyanocobalamin API Revenue by Type (2027-2032) & (K Units) Table 26. Global Cyanocobalamin API Revenue Market Share by Type (2021-2026) Table 27. Global Cyanocobalamin API Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Contract Manufacturing Organizations Table 29. Major Manufacturers of Pharmaceutical Companies Table 30. Major Manufacturers of Others Table 31. Global Cyanocobalamin API Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Cyanocobalamin API Sales by Application (2021-2026) & (K Units) Table 33. Global Cyanocobalamin API Sales by Application (2027-2032) & (K Units) Table 34. Global Cyanocobalamin API Sales Market Share by Application (2021-2026) Table 35. Global Cyanocobalamin API Sales Market Share by Application (2027-2032) Table 36. Global Cyanocobalamin API Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Cyanocobalamin API Revenue by Application (2021-2026) & (K Units) Table 38. Global Cyanocobalamin API Revenue by Application (2027-2032) & (K Units) Table 39. Global Cyanocobalamin API Revenue Market Share by Application (2021-2026) Table 40. Global Cyanocobalamin API Revenue Market Share by Application (2027-2032) Table 41. Global Cyanocobalamin API Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Cyanocobalamin API Sales by Region (2021-2026) & (K Units) Table 43. Global Cyanocobalamin API Sales Market Share by Region (2021-2026) Table 44. Global Cyanocobalamin API Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Cyanocobalamin API Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Cyanocobalamin API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Cyanocobalamin API Sales by Country (2021-2026) & (K Units) Table 48. North America Cyanocobalamin API Sales by Country (2027-2032) & (K Units) Table 49. Europe Cyanocobalamin API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Cyanocobalamin API Sales by Country (2021-2026) & (K Units) Table 51. Europe Cyanocobalamin API Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Cyanocobalamin API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Cyanocobalamin API Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Cyanocobalamin API Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Cyanocobalamin API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Cyanocobalamin API Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Cyanocobalamin API Sales by Country (2027-2032) & (K Units) Table 58. Global Cyanocobalamin API Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Cyanocobalamin API Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Cyanocobalamin API Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Cyanocobalamin API Revenue Market Share by Region (2021-2026) Table 62. Global Cyanocobalamin API Revenue Market Share by Region (2027-2032) Table 63. Sanofi Company Information Table 64. Sanofi Business Overview Table 65. Sanofi Cyanocobalamin API Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Sanofi Cyanocobalamin API Product Portfolio Table 67. Sanofi Recent Development Table 68. Kingvit Company Information Table 69. Kingvit Business Overview Table 70. Kingvit Cyanocobalamin API Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Kingvit Cyanocobalamin API Product Portfolio Table 72. Kingvit Recent Development Table 73. North China Pharmaceutical Group Company Information Table 74. North China Pharmaceutical Group Business Overview Table 75. North China Pharmaceutical Group Cyanocobalamin API Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. North China Pharmaceutical Group Cyanocobalamin API Product Portfolio Table 77. North China Pharmaceutical Group Recent Development Table 78. Hebei Yuxing Bio-Engineering Company Information Table 79. Hebei Yuxing Bio-Engineering Business Overview Table 80. Hebei Yuxing Bio-Engineering Cyanocobalamin API Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Hebei Yuxing Bio-Engineering Cyanocobalamin API Product Portfolio Table 82. Hebei Yuxing Bio-Engineering Recent Development Table 83. Hebei Huarong Pharmaceutical Company Information Table 84. Hebei Huarong Pharmaceutical Business Overview Table 85. Hebei Huarong Pharmaceutical Cyanocobalamin API Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Hebei Huarong Pharmaceutical Cyanocobalamin API Product Portfolio Table 87. Hebei Huarong Pharmaceutical Recent Development Table 88. GlaxoSmithKline Company Information Table 89. GlaxoSmithKline Business Overview Table 90. GlaxoSmithKline Cyanocobalamin API Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. GlaxoSmithKline Cyanocobalamin API Product Portfolio Table 92. GlaxoSmithKline Recent Development Table 93. Wockhardt Company Information Table 94. Wockhardt Business Overview Table 95. Wockhardt Cyanocobalamin API Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Wockhardt Cyanocobalamin API Product Portfolio Table 97. Wockhardt Recent Development Table 98. Rochem International Company Information Table 99. Rochem International Business Overview Table 100. Rochem International Cyanocobalamin API Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Rochem International Cyanocobalamin API Product Portfolio Table 102. Rochem International Recent Development Table 103. EuroAPI Company Information Table 104. EuroAPI Business Overview Table 105. EuroAPI Cyanocobalamin API Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. EuroAPI Cyanocobalamin API Product Portfolio Table 107. EuroAPI Recent Development Table 108. Bristol Myers Squibb Company Information Table 109. Bristol Myers Squibb Business Overview Table 110. Bristol Myers Squibb Cyanocobalamin API Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Bristol Myers Squibb Cyanocobalamin API Product Portfolio Table 112. Bristol Myers Squibb Recent Development Table 113. Basic Nutrition Company Information Table 114. Basic Nutrition Business Overview Table 115. Basic Nutrition Cyanocobalamin API Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Basic Nutrition Cyanocobalamin API Product Portfolio Table 117. Basic Nutrition Recent Development Table 118. Antibiotice Company Information Table 119. Antibiotice Business Overview Table 120. Antibiotice Cyanocobalamin API Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Antibiotice Cyanocobalamin API Product Portfolio Table 122. Antibiotice Recent Development Table 123. Key Raw Materials Table 124. Raw Materials Key Suppliers Table 125. Cyanocobalamin API Distributors List Table 126. Cyanocobalamin API Customers List Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Cyanocobalamin API Product Image Figure 2. Global Cyanocobalamin API Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cyanocobalamin API Market Size (2021-2032) & (US$ Million) Figure 4. Global Cyanocobalamin API Sales (2021-2032) & (K Units) Figure 5. Global Cyanocobalamin API Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Cyanocobalamin API Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Crystal Image Figure 9. Powder Image Figure 10. Global Cyanocobalamin API Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Cyanocobalamin API Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Cyanocobalamin API Sales Market Share by Type (2021-2032) Figure 13. Global Cyanocobalamin API Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Cyanocobalamin API Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Cyanocobalamin API Revenue Market Share by Type (2021-2032) Figure 16. Contract Manufacturing Organizations Image Figure 17. Pharmaceutical Companies Image Figure 18. Others Image Figure 19. Global Cyanocobalamin API Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Cyanocobalamin API Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Cyanocobalamin API Sales Market Share by Application (2021-2032) Figure 22. Global Cyanocobalamin API Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Cyanocobalamin API Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Cyanocobalamin API Revenue Market Share by Application (2021-2032) Figure 25. North America Cyanocobalamin API Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Cyanocobalamin API Sales Market Share by Country (2021-2032) Figure 27. U.S. Cyanocobalamin API Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Cyanocobalamin API Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Cyanocobalamin API Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Cyanocobalamin API Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Cyanocobalamin API Sales Market Share by Country (2021-2032) Figure 32. Germany Cyanocobalamin API Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Cyanocobalamin API Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Cyanocobalamin API Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Cyanocobalamin API Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Cyanocobalamin API Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Cyanocobalamin API Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Cyanocobalamin API Sales Market Share by Country (2021-2032) Figure 39. China Cyanocobalamin API Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Cyanocobalamin API Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Cyanocobalamin API Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Cyanocobalamin API Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Cyanocobalamin API Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Cyanocobalamin API Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Cyanocobalamin API Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Cyanocobalamin API Sales Market Share by Country (2021-2032) Figure 47. Brazil Cyanocobalamin API Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Cyanocobalamin API Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Cyanocobalamin API Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Cyanocobalamin API Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Cyanocobalamin API Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Cyanocobalamin API Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Cyanocobalamin API Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Cyanocobalamin API Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Cyanocobalamin API Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Cyanocobalamin API Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Cyanocobalamin API Revenue (2021-2032) & (US$ Million) Figure 58. North America Cyanocobalamin API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Cyanocobalamin API Revenue (2021-2032) & (US$ Million) Figure 60. Europe Cyanocobalamin API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Cyanocobalamin API Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Cyanocobalamin API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Cyanocobalamin API Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Cyanocobalamin API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Cyanocobalamin API Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Cyanocobalamin API Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Crystal
  • Powder
Applications
  • Contract Manufacturing Organizations
  • Pharmaceutical Companies
  • Others
Companies covered
  • Sanofi
  • Kingvit
  • North China Pharmaceutical Group
  • Hebei Yuxing Bio-Engineering
  • Hebei Huarong Pharmaceutical
  • GlaxoSmithKline
  • Wockhardt
  • Rochem International
  • EuroAPI
  • Bristol Myers Squibb
  • Basic Nutrition
  • Antibiotice

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cyanocobalamin API Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cyanocobalamin API Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Cyanocobalamin API Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Cyanocobalamin API Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Cyanocobalamin API Market Dynamics
  1. 2.1 Cyanocobalamin API Industry Trends
  2. 2.2 Cyanocobalamin API Industry Drivers
  3. 2.3 Cyanocobalamin API Industry Opportunities and Challenges
  4. 2.4 Cyanocobalamin API Industry Restraints
3 Cyanocobalamin API Market by Manufacturers
  1. 3.1 Global Cyanocobalamin API Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Cyanocobalamin API Sales by Manufacturers (2021-2026)
  3. 3.3 Global Cyanocobalamin API Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Cyanocobalamin API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cyanocobalamin API Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Cyanocobalamin API Manufacturers, Product Type & Application
  7. 3.7 Global Cyanocobalamin API Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cyanocobalamin API Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cyanocobalamin API Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cyanocobalamin API Tier 1, Tier 2, and Tier 3
4 Cyanocobalamin API Market by Type
  1. 4.1 Cyanocobalamin API Type Introduction
  2. 4.1.1 Crystal
  3. 4.1.2 Powder
  4. 4.2 Global Cyanocobalamin API Sales by Type
  5. 4.2.1 Global Cyanocobalamin API Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Cyanocobalamin API Sales by Type (2021-2032)
  7. 4.2.3 Global Cyanocobalamin API Sales Market Share by Type (2021-2032)
  8. 4.3 Global Cyanocobalamin API Revenue by Type
  9. 4.3.1 Global Cyanocobalamin API Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Cyanocobalamin API Revenue by Type (2021-2032)
  11. 4.3.3 Global Cyanocobalamin API Revenue Market Share by Type (2021-2032)
5 Cyanocobalamin API Market by Application
  1. 5.1 Cyanocobalamin API Application Introduction
  2. 5.1.1 Contract Manufacturing Organizations
  3. 5.1.2 Pharmaceutical Companies
  4. 5.1.3 Others
  5. 5.2 Global Cyanocobalamin API Sales by Application
  6. 5.2.1 Global Cyanocobalamin API Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Cyanocobalamin API Sales by Application (2021-2032)
  8. 5.2.3 Global Cyanocobalamin API Sales Market Share by Application (2021-2032)
  9. 5.3 Global Cyanocobalamin API Revenue by Application
  10. 5.3.1 Global Cyanocobalamin API Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Cyanocobalamin API Revenue by Application (2021-2032)
  12. 5.3.3 Global Cyanocobalamin API Revenue Market Share by Application (2021-2032)
6 Global Cyanocobalamin API Sales by Region
  1. 6.1 Global Cyanocobalamin API Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cyanocobalamin API Sales by Region (2021-2032)
  3. 6.2.1 Global Cyanocobalamin API Sales by Region (2021-2026)
  4. 6.2.2 Global Cyanocobalamin API Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cyanocobalamin API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Cyanocobalamin API Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Cyanocobalamin API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Cyanocobalamin API Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Cyanocobalamin API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Cyanocobalamin API Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Cyanocobalamin API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Cyanocobalamin API Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Cyanocobalamin API Revenue by Region
  1. 7.1 Global Cyanocobalamin API Revenue by Region
  2. 7.1.1 Global Cyanocobalamin API Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Cyanocobalamin API Revenue by Region (2021-2026)
  4. 7.1.3 Global Cyanocobalamin API Revenue by Region (2027-2032)
  5. 7.1.4 Global Cyanocobalamin API Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Cyanocobalamin API Revenue (2021-2032)
  8. 7.2.2 North America Cyanocobalamin API Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Cyanocobalamin API Revenue (2021-2032)
  11. 7.3.2 Europe Cyanocobalamin API Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Cyanocobalamin API Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Cyanocobalamin API Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Cyanocobalamin API Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Cyanocobalamin API Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Cyanocobalamin API Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Cyanocobalamin API Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Kingvit
  8. 8.2.1 Kingvit Company Information
  9. 8.2.2 Kingvit Business Overview
  10. 8.2.3 Kingvit Cyanocobalamin API Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Kingvit Cyanocobalamin API Product Portfolio
  12. 8.2.5 Kingvit Recent Developments
  13. 8.3 North China Pharmaceutical Group
  14. 8.3.1 North China Pharmaceutical Group Company Information
  15. 8.3.2 North China Pharmaceutical Group Business Overview
  16. 8.3.3 North China Pharmaceutical Group Cyanocobalamin API Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 North China Pharmaceutical Group Cyanocobalamin API Product Portfolio
  18. 8.3.5 North China Pharmaceutical Group Recent Developments
  19. 8.4 Hebei Yuxing Bio-Engineering
  20. 8.4.1 Hebei Yuxing Bio-Engineering Company Information
  21. 8.4.2 Hebei Yuxing Bio-Engineering Business Overview
  22. 8.4.3 Hebei Yuxing Bio-Engineering Cyanocobalamin API Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hebei Yuxing Bio-Engineering Cyanocobalamin API Product Portfolio
  24. 8.4.5 Hebei Yuxing Bio-Engineering Recent Developments
  25. 8.5 Hebei Huarong Pharmaceutical
  26. 8.5.1 Hebei Huarong Pharmaceutical Company Information
  27. 8.5.2 Hebei Huarong Pharmaceutical Business Overview
  28. 8.5.3 Hebei Huarong Pharmaceutical Cyanocobalamin API Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hebei Huarong Pharmaceutical Cyanocobalamin API Product Portfolio
  30. 8.5.5 Hebei Huarong Pharmaceutical Recent Developments
  31. 8.6 GlaxoSmithKline
  32. 8.6.1 GlaxoSmithKline Company Information
  33. 8.6.2 GlaxoSmithKline Business Overview
  34. 8.6.3 GlaxoSmithKline Cyanocobalamin API Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GlaxoSmithKline Cyanocobalamin API Product Portfolio
  36. 8.6.5 GlaxoSmithKline Recent Developments
  37. 8.7 Wockhardt
  38. 8.7.1 Wockhardt Company Information
  39. 8.7.2 Wockhardt Business Overview
  40. 8.7.3 Wockhardt Cyanocobalamin API Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Wockhardt Cyanocobalamin API Product Portfolio
  42. 8.7.5 Wockhardt Recent Developments
  43. 8.8 Rochem International
  44. 8.8.1 Rochem International Company Information
  45. 8.8.2 Rochem International Business Overview
  46. 8.8.3 Rochem International Cyanocobalamin API Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Rochem International Cyanocobalamin API Product Portfolio
  48. 8.8.5 Rochem International Recent Developments
  49. 8.9 EuroAPI
  50. 8.9.1 EuroAPI Company Information
  51. 8.9.2 EuroAPI Business Overview
  52. 8.9.3 EuroAPI Cyanocobalamin API Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 EuroAPI Cyanocobalamin API Product Portfolio
  54. 8.9.5 EuroAPI Recent Developments
  55. 8.10 Bristol Myers Squibb
  56. 8.10.1 Bristol Myers Squibb Company Information
  57. 8.10.2 Bristol Myers Squibb Business Overview
  58. 8.10.3 Bristol Myers Squibb Cyanocobalamin API Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Bristol Myers Squibb Cyanocobalamin API Product Portfolio
  60. 8.10.5 Bristol Myers Squibb Recent Developments
  61. 8.11 Basic Nutrition
  62. 8.11.1 Basic Nutrition Company Information
  63. 8.11.2 Basic Nutrition Business Overview
  64. 8.11.3 Basic Nutrition Cyanocobalamin API Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Basic Nutrition Cyanocobalamin API Product Portfolio
  66. 8.11.5 Basic Nutrition Recent Developments
  67. 8.12 Antibiotice
  68. 8.12.1 Antibiotice Company Information
  69. 8.12.2 Antibiotice Business Overview
  70. 8.12.3 Antibiotice Cyanocobalamin API Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Antibiotice Cyanocobalamin API Product Portfolio
  72. 8.12.5 Antibiotice Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cyanocobalamin API Value Chain Analysis
  2. 9.1.1 Cyanocobalamin API Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cyanocobalamin API Production Mode & Process
  6. 9.2 Cyanocobalamin API Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cyanocobalamin API Distributors
  9. 9.2.3 Cyanocobalamin API Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst